(Reuters) – The U.S. Food and Drug Administration approved AcuFocus Inc’s corneal implant to improve vision in patients with presbyopia, an age-related eye disorder.
The device, KAMRA inlay, is the first implantable device to correct vision in patients who have not had cataract surgery, the FDA said in a statement on Friday. (http://1.usa.gov/1Hh1g7V)
Presbyopia is a condition associated with aging in which the eye exhibits a diminished ability to focus on near objects.
(Reporting by Rosmi Shaji in Bengaluru; Editing by Saumyadeb Chakrabarty)
- FDA